TriMas Q2 Adjusted EPS Soars 160% on Cost Cuts, Raises 2026 Outlook
TRS sits 27% above its 52-week low of $30.43.
Summary
TriMas delivered a strong Q2, with adjusted EPS of $0.52 beating consensus by 6% and jumping 160% year-over-year, driven by aggressive cost reductions and a lower share count from buybacks. Revenue of $174.6M missed estimates slightly, but the bottom-line beat and raised full-year adjusted EPS guidance to $1.60-$1.70 (from $1.50-$1.70) signal improving profitability. The company repurchased over 5 million shares since November 2025, amplifying per-share earnings, while interest income from the $1.45B Aerospace divestiture cash pile further boosted results. Specialty Products saw 10.2% sales growth, though margin compression from raw material cost lags and manufacturing inefficiencies bears watching. With a leaner cost structure and a clear path to 300+ bps of operating margin improvement in 2026, the raised outlook confirms the turnaround is gaining traction.
At the time of this announcement, TRS was trading at $38.61 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $30.43 to $45.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.